Entrectinib
id:
entrectinib-184-7161503
title:
Entrectinib
text:
Entrectinib, sold under the brand name Rozlytrek, is an anti-cancer medication used to treat ROS1-positive non-small cell lung cancer and NTRK fusion-positive solid tumors. It is a selective tyrosine kinase inhibitor (TKI), of the tropomyosin receptor kinases (TRK) A, B and C, C-ros oncogene 1 (ROS1) and anaplastic lymphoma kinase (ALK). The most common side effects include tiredness, constipation, dysgeusia, edema, dizziness, diarrhea, nausea, dysesthesia, dyspnea, anemia, increased weight, inc
brand slug:
wiki
category slug:
encyclopedia
description:
TKI inhibitor used for cancer treatment
original url:
https://en.wikipedia.org/wiki/Entrectinib
date created:
2016-04-20T11:58:15Z
date modified:
2024-09-07T05:42:37Z
main entity:
{"identifier":"Q25323953","url":"https://www.wikidata.org/entity/Q25323953"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/4/42/Entrectinib.svg","width":512,"height":353}
fields total:
13
integrity:
16